GlucoTrack director Paul V. Goode resigns citing potential conflict of interest
GCTK•Director resignation
- GlucoTrack director Paul V. Goode resigned from the board on Sept. 14, 2026, effective immediately.
- Goode cited a potential conflict of interest tied to talks over duties and obligations under the Lokahi Therapeutics merger agreement.
